COSCIENS Biopharma Inc. Announces Details of Share Capital Amendment

COSCIENS Biopharma Inc. has outlined its plans for amending its share capital, a move that follows shareholder approval at the annual meeting. This amendment could signify a strategic shift, possibly aimed at bolstering the company’s financial position or facilitating future growth opportunities. Such changes in share capital are significant for investors, as they can impact the company's valuation and shareholder equity. This move suggests COSCIENS is taking proactive steps to enhance its market position and operational flexibility.